🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vallerie V. McLaughlin

University of Michigan

ORCID: 0000-0002-8907-1651

Also affiliated with Michigan Medicine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile
2.3Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE

The Journal of Heart and Lung Transplantation(2021)10.1016/j.healun.2021.01.006
Top 16%
1.3DataRank
Top 16%23 citations

Anna R. Hemnes, Murali M. Chakinala, Kristin B. Highland, Kelly Chin, Vallerie V. McLaughlin +4 more

Papers

Driven by 11 papers — median percentile 82. Top paper: “Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry”.

Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry

CHEST Journal(2021)10.1016/j.chest.2021.05.052
N/A
2.4DataRank · unranked
74 citations

C. Gregory Elliott, Kelly Chin, Raymond L. Benza, Richard N. Channick, R. Duane Davis +12 more

Patient and disease characteristics of the first 500 patients with pulmonary arterial hypertension treated with selexipag in real-world settings from SPHERE

The Journal of Heart and Lung Transplantation(2021)10.1016/j.healun.2021.01.006
Top 16%
1.3DataRank
Top 16%23 citations

Anna R. Hemnes, Murali M. Chakinala, Kristin B. Highland, Kelly Chin, Vallerie V. McLaughlin +4 more

Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis

Arthritis & Rheumatology(2020)10.1002/art.41246
N/A
1.1DataRank · unranked
38 citations

Marco Matucci‐Cerinic, Daniel E. Furst, Masataka Kuwana, Yannick Allanore, Christopher P. Denton +8 more

Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)

The Journal of Heart and Lung Transplantation(2023)10.1016/j.healun.2023.09.016
Top 20%
0.995DataRank
Top 20%27 citations

Harrison W. Farber, Kristin B. Highland, Anna R. Hemnes, Murali M. Chakinala, Kelly Chin +6 more

AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study

ERJ Open Research(2022)10.1183/23120541.00433-2022
N/A
0.880DataRank · unranked
27 citations

Ralph W. Niven, Benjamin T. Dake, Murali M. Chakinala, Jeremy P. Feldman, Nicholas S. Hill +5 more

Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension

CHEST Journal(2021)10.1016/j.chest.2021.01.066
N/A
0DataRank · unranked
38 citations

Olivier Sitbon, Richard N. Channick, Kelly Chin, Rafael Sauter, Nazzareno Galiè +9 more

Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort

Arthritis & Rheumatology(2021)10.1002/art.41732
N/A
0DataRank · unranked
43 citations

Victor Moles, Sara Jaafar, Scott Visovatti, Suiyuan Huang, Dharshan Vummidi +4 more

Exercise Rehabilitation is Underutilized Among Veterans With Pulmonary Hypertension

The American Journal of Cardiology(2023)10.1016/j.amjcard.2023.08.095
N/A
0DataRank · unranked
1 citations

David W. Schopfer, Craig S. Meyer, Ning Zhang, Geoffrey D. Barnes, Vallerie V. McLaughlin +3 more

A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension

The Journal of Heart and Lung Transplantation(2024)10.1016/j.healun.2024.09.021
N/A
0DataRank · unranked
20 citations

Adriano R. Tonelli, Victor Moles, Vallerie V. McLaughlin, Thomas Cascino

Highlights for the Heart Failure Cardiologist from the Seventh World Symposium on Pulmonary Hypertension: Are We Out of the Woods Yet?

Journal of Cardiac Failure(2024)10.1016/j.cardfail.2024.09.009
N/A
0DataRank · unranked
2 citations

Bradley A. Maron, Jean‐Luc Vachiéry, Vallerie V. McLaughlin, Ryan J. Tedford, Thomas Cascino

Safety Window for Effective Lesion Crossing in Patients With Chronic Thromboembolic Pulmonary Hypertension

Journal of the Society for Cardiovascular Angiography & Interventions(2024)10.1016/j.jscai.2024.102142
N/A
0DataRank · unranked
1 citations

Miguel Lora Funes, Daniel S Cheah, Christian Argenti, Jorge Vinales, David Gordon +11 more